FDA proposes delayed track and trace rollout; GSK forays into artificial intelligence-aided drug research
This week, Phispers brings you news on an apex court ruling in Canada that overhauls its patent law
Compliance Wrap: Heparin quality concerns re-emerge in China, more trouble at Sun Pharma & Wockhardt
PharmaCompass looks at recent compliance concerns highlighted by the US FDA at drug manufacturers li
If deleting electronic records is okay, then it must be okay to rip out pages from lab notebooks
This week, Speak Pharma interviews Mark S.
Paxton, the Chief Executive Officer of Rx-360, a non-prof
Phispers: Another Heparin scandal in China, GSK may have a new CEO, Female libido pill problems
Pharmaceutical Whispers (Phispers) this week cover another major heparin scandal emanating from